drugset / Trial / NCT01111422

Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients

NCT01111422

Phase 4 Unknown 66 enrolled Ewha Womans University
RandomizedParallel-groupOpen-labelTreatment

Summary

Peritoneal fibrosis is one of the major causes of technical failure in patients on peritoneal dialysis (PD) for long period of time. Although the exact mechanisms of peritoneal damage during PD still remain unclear, generation of reactive oxygen species may be responsible for progressive membrane dysfunction. N-acetylcysteine (NAC)is a powerful antioxidant shown to protect peritoneal fibrosis in peritoneal dialysis animal model. In this study the researchers investigated the hypothesis that NAC protect peritoneal membrane damage.

Timeline

Start
2010-03
Primary completion
2010-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 600 mg